We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Urges Caution on Moving Medicare Part B Drugs to Rx Benefit
HHS Urges Caution on Moving Medicare Part B Drugs to Rx Benefit
April 1, 2005
Shifting some categories of Medicare Part B drugs to Part D could fuel competitive pressures on pharmaceutical pricing, but the HHS does not recommend consolidating coverage of the products until the Medicare prescription drug benefit has had a chance to get up and running, a new report says.